e-fundresearch.com: Mr Christian Fay, you are the fund manager of the Parvest Equity World Health Care fund (ISIN: LU0823416762 – Classic Capitalisation share). When did you take over the responsibility of managing this fund?
Christian Fay: I began managing this fund in May 2013. The fund itself has a trackrecord since 1997.
e-fundresearch.com: What is the current size of the fund?
Christian Fay: As of end of August, the size of the fund was EUR261.9m.
e-fundresearch.com: Do you also manage other funds or mandates?
Christian Fay: Yes, I also manage the Parvest Equity World Materials since August 2013 (ISIN: LU0823419436 – Classic Capitalisation share).
e-fundresearch.com: What is the total amount of assets you manage currently?
Christian Fay: Overall, I manage EUR363.1m (figure as of end of August).
e-fundresearch.com: How long have you been in the business as a fund manager?
Christian Fay: I have seven years of business experience as a fund manager.
e-fundresearch.com: What are the main steps in your investment process and in which area is your competitive edge to add value to investors?
Christian Fay: The investment process for all of our Global Sector Funds, including Parvest Equity World Health Care, is based on fundamental, bottom-up analysis, following the very disciplined and consistent investment process already successfully in place for our US equity strategies.
Our investment approach draws from decades of investment experience, based on a disciplined and proven process, which is rigorous but responsive and aims to add value at each step. We apply a fundamental, bottom-up, approach combining quantitative discipline with stock specific insight, culminating in a diversified portfolio with a heavy emphasis on stock selection.
Stock selection reflects our experience and judgment supported by fact-based research. We apply complementary layers of fundamental analysis: systematic analysis and fundamental company research. The goal of the systematic evaluation is to reduce the large universe of stocks into a manageable pool for deeper analysis. Our fundamental company research aims to identify attractive opportunities under the current market environment.
Our goal is to add value through disciplined and consistent stock selection.
Our experience, together with the different layers of fundamental analysis in our investment process, enables us to identify and retain the best opportunities in the current market environment.
e-fundresearch.com: Which benchmark is most relevant and how should investors compare the fund vs. benchmarks or peer groups?
Christian Fay: Our chosen benchmark for our Health Care equity strategy is the MSCI World Health Care 10/40 Index (EUR) (NR). MSCI is a leading benchmark provider globally covering the universe of the most liquid equities. We view this index as the most representative of the investment universe.
The fund is an actively managed fund that aims to deliver 200-400 basis points out-performance over a full market cycle, while maintaining a tracking error target of 4% (max: 7%).
e-fundresearch: Which performance did you achieve for the fund YTD and over the past five calendar years in absolute terms and relative to relevant benchmark or other reference indices?
Christian Fay:
e-fundresearch.com: Thank you!
Verwandte Artikel:
Die besten Pharma und Biotechnologie Aktienfonds
